New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Fractyl Health, Inc. (GUTS) vs Neuphoria Therapeutics Inc. (NEUP)

Fractyl Health, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Fractyl Health, Inc. and Neuphoria Therapeutics Inc. are of similar size ($12.7M and $12.6M). Across the 11 metrics below, Neuphoria Therapeutics Inc. leads on 6 and Fractyl Health, Inc. on 5.

Valuation

Metric GUTS NEUP Biotechnology median
P/E n/m n/m 8.49
P/S 118.25 0.81 8.56
P/B n/m 0.54 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA n/m 0.45 0.69
EV/Sales 93.73 (0.38) 8.00
Earnings yield (374.54%) (38.02%) (35.81%)
Free cash flow yield (685.81%) (76.18%) (25.41%)

Profitability

Metric GUTS NEUP Biotechnology median
Gross margin 46.24% — 70.18%
Operating margin (100,570.97%) — 0.00%
Net margin (75,732.26%) — 0.00%
Free cash flow margin (72,350.54%) — 0.00%
Return on equity 905.17% (27.63%) (51.58%)
Return on assets (82.35%) (18.26%) (45.91%)
Return on invested capital 0.00% (186.04%) 0.00%

Growth

Metric GUTS NEUP Biotechnology median
Revenue growth (TTM) (22.50%) — 7.20%
EPS growth (last fiscal year) (14.81%) (1,230.43%) 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric GUTS NEUP Biotechnology median
Debt to equity (2.21) 0.00 0.00
Current ratio 1.98 18.05 4.79
Net debt to EBITDA 0.53 1.26 1.01

Dividend

Metric GUTS NEUP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS NEUP Biotechnology median
Market cap 12.67m 12.55m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack